S1802
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Trial overview
| Disease | Prostate cancer treatment & diagnosis |
| Topic | S1802 |
| Description | Primary Objective To compare overall survival in metastatic prostate cancer patients who are randomized to standard systemic therapy (SST) plus definitive treatment of the primary tumor versus standard systemic therapy alone. |
| Physicians | Dr. Thomas BoikeMD Radiation Oncologist Works at 3 centers.Dr. Larry L. KestinMD, FACR Radiation Oncologist Works at 3 centers.Dr. Alvaro A. MartinezMD, FACR, FABS, FASTRO Radiation Oncologist Works at 5 centers.Dr. Frank A. ViciniMD, FACR, FASTRO Radiation oncologist Works at 3 centers.Dr. John Vito AntonucciMD Radiation Oncologist Works at 4 centers.Dr. Michael I. GhilezanMD, PhD Radiation Oncologist Works at 4 centers. |